TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
24 hedge funds and large institutions have $3.55M invested in Titan Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
-11
Holders Change %
-31.43%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
9
Closed
14
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$191K
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$467K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$341K |
| 3 |
Goldman Sachs
New York
|
-$195K |
| 4 |
ECM
Element Capital Management
New York
|
-$156K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$136K |
